Evidence map›Paper›PMID 36501041›Full record

ArticleNutrients2022

Impact of Impulsivity and Therapy Response in Eating Disorders from a Neurophysiological, Personality and Cognitive Perspective.

Giulia Testa, Roser Granero, Alejandra Misiolek, Cristina Vintró-Alcaraz, Núria Mallorqui-Bagué, Maria Lozano-Madrid, Misericordia Veciana De Las Heras, Isabel Sánchez, Susana Jiménez-Murcia, Fernando Fernández-Aranda

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. The current clinical approach to feeding and eating disorders aimed to increase personalization of management.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Applying psycho-behavioural phenotyping in obesity characterization.Reviews in endocrine & metabolic disorders · 2023
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Giulia TestaUniversidad Internacional de La Rioja, 26006 La Rioja, Spain.ORCID 0000-0003-4200-8062
Roser GraneroCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.ORCID 0000-0001-6308-3198
Alejandra MisiolekPsychoneurobiology of Eating and Addictive Behaviors Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 Barcelona, Spain.
Cristina Vintró-AlcarazCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.ORCID 0000-0001-9453-8810
Núria Mallorqui-BaguéCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.ORCID 0000-0003-1434-3162
Maria Lozano-MadridPsychoneurobiology of Eating and Addictive Behaviors Group, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 Barcelona, Spain.
Misericordia Veciana De Las HerasNeurophysiology Unit, Neurology Department, Hospital Universitari de Bellvitge, 08908 L'Hospitalet de Llobregat, Spain.
Isabel SánchezCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
Susana Jiménez-MurciaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.
Fernando Fernández-ArandaCIBER Physiology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.ORCID 0000-0002-2968-9898
Instituto de Salud Carlos III · ESInstitut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ESUniversitat Autònoma de Barcelona · ESUniversitat de Girona · ES

Funding

CERCA Institution FIS PI14/00290, PI17/01167, PI20/132Ministerio de Educación y Cultura FPU15/02911 and FPU16/01453
6 · The paper itself

Abstract

Impulsivity, as a multidimensional construct, has been linked to eating disorders (EDs) and may negatively impact treatment response. The study aimed to identify the dimensions of impulsivity predicting poor remission of ED symptoms. A total of 37 ED patients underwent a baseline assessment of impulsive personality traits and inhibitory control, including the Stroop task and the emotional go/no-go task with event-related potentials (ERPs) analysis. The remission of EDs symptomatology was evaluated after 3 months of cognitive-behavioral therapy (CBT) and at a 2-year follow-up. Poor remission after CBT was predicted by poor inhibitory control, as measured by the Stroop task. At 2 years, the risk of poor remission was higher in patients with higher novelty seeking, lower inhibitory control in the Stroop and in ERPs indices (N2 amplitudes) during the emotional go/no-go task. The present results highlight inhibitory control negatively impacting both short- and long-term symptomatology remission in ED patients. On the other hand, high novelty seeking and ERPs indices of poor inhibition seem to be more specifically related to long-term remission. Therefore, a comprehensive assessment of the impulsivity dimension in patients with ED is recommended to tailor treatments and improve their efficacy.

Indexed as

Feeding and Eating DisordersImpulsive BehaviorCognitionHumansInhibition, PsychologicalPersonalityeating disordersevent-related potentialsimpulsivity traitsinhibitory controltreatment outcome

Identifiers

PMID36501041
PMCPMC9738347
OpenAlexW4310038314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.